Corcept Therapeutics
Organisation
Trials
Phase 1, Completed, 2021, 82 people, 12 Aug 2021, clinicaltrials.gov
Phase 1, Completed, 2020, 115 people, 17 Dec 2020, clinicaltrials.gov
Phase 1, Completed, 2020, 110 people, 30 Jan 2020, clinicaltrials.gov
Phase 1, Completed, 2019, 96 people, 15 Mar 2019, clinicaltrials.gov
Phase 1, Completed, 2014, 130 people, 26 Apr 2018, clinicaltrials.gov
Phase 1, Completed, 2018, 27 people, 7 Mar 2018, clinicaltrials.gov
Phase 1, Completed, 2017, 48 people, 8 Nov 2017, clinicaltrials.gov
Phase 1, Completed, 2017, 143 people, 20 Oct 2017, clinicaltrials.gov
Papers
ADA Scientific Sessions 2026 abstract, 6 Jun 2026
All-Cause Mortality and GI Adverse Effects in Adults with Type 1 Diabetes (T1D) on GLP-1RA
ADA Scientific Sessions 2025 abstract, 13 Jun 2025
ADA Scientific Sessions 2025 abstract, 13 Jun 2025
Beta-Cell Preservation with Early Oral Antidiabetic Medications in Prediabetes (PreDM)
ADA Scientific Sessions 2025 abstract, 13 Jun 2025